Recomendado

Penile Foreign Bodies.

Isquemia Fría Y Supervivencia Del Injerto. Dif...

Fístula Rectovaginal Y Enterocutánea Espontá...

Dermatological Side Effects Of Intravesical Mit...

Extravasación De Mitomicina Tras Instilación ...

0 votes
Effectiveness Of Low-intensity Extracorporeal Shock Wave Therapy On Patients With Erectile Dysfunction (ed) Who Have Failed To Respond To Pde5i Therapy. A Pilot Study.
Autor: A. Bechara, A, Casabé, W. De Bonis Y J. Nazar.
Editorial: Archivos Españoles de Urología
9 páginas
Pago único: €6.20
Requiere suscripción: Académico
Tipo de publicación: Articulo
Follow this publisher

Comparte esta publicación:

Descripción:

Low-intensity extracorporeal shock wave therapy (LIESWT) of the penis has recently emerged as a promising modality in the treatment of ED.

OBJECTIVES: The objective of this paper is to assess the effectiveness and safety of LIESWT on patients with ED who have failed to respond to PDE5i treatment.

METHODS: Open label, prospective, longitudinal observational study. The study involved an uncontrolled population of 25 patients. The treatment consisted in applying 20,000 shock waves during a period of four weeks. In each session the patient received 5000 shock waves of 0.09 mJ/mm2: 1800 were applied on the penis (900 on each corpus cavernosum), and 3200 were applied on the perineum (1600 on each crus). During the active treatment and follow-up phases, all patients remained on their regular high on demand or once-a-day dose PDE5i schedules.

Main Outcome Measures: Effectiveness was assessed by IIEF-6, SEP2, SEP3 and GAQ. Patients were considered to be responders whenever they improved on all three erection assessment parameters and respond positively to the GAQ at three months post-treatment. Adverse events were recorded. Statistical variables were applied and findings were considered to be statistically significant whenever the P value was < 0.05.

RESULTS: Eighty percent (median age 63) of the patients (20/25) completed the study. Five patients were lost to follow-up and were excluded from the analysis.

Sixty percent (60%) of the patients responded to the treatment, improved the 3 efficacy evaluating parameters and responded positively to the GAQ. The increase in mean IIEF-6 score was of 9 points after the third post-treatment month. There were no patients reporting treatment-related adverse events.

CONCLUSIONS: LIESWT for men with ED and that are PDE5i non-responders was safe and effective and restoring PDE5i response in more than 50% of patients. A large-scale multicenter study is required to determine the benefits of this treatment for ED.

Sobre el editor:

Revista Internacional de Urología indexada y peer-reviewed, fundada en 1944, dirigida a toda la comunidad científica. Aquí encontrarás las últimas novedades y hallazgos urológicos. Publicamos 10 números anuales.